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Abstract Ammonia is a neurotoxin involved in the
pathogenesis of neurological conditions associated with
hyperammonemia, including hepatic encephalopathy, a
condition associated with acute—(ALF) or chronic liver
failure. This article reviews evidence that apart from
directly affecting the metabolism and function of the cen-
tral nervous system cells, ammonia inﬂuences the passage
of different molecules across the blood brain barrier
(BBB). A brief description is provided of the tight junc-
tions, which couple adjacent cerebral capillary endothelial
cells to each other to form the barrier. Ammonia modulates
the transcellular passage of low-to medium-size molecules,
by affecting their carriers located at the BBB. Ammonia
induces interrelated aberrations of the transport of the large
neutral amino acids and aromatic amino acids (AAA),
whose inﬂux is augmented by exchange with glutamine
produced in the course of ammonia detoxiﬁcation, and
maybe also modulated by the extracellularly acting
gamma-glutamyl moiety transferring enzyme, gamma-
glutamyl-transpeptidase. Impaired AAA transport affects
neurotransmission by altering intracerebral synthesis of
catecholamines (serotonin and dopamine), and producing
‘‘false neurotransmitters’’ (octopamine and phenylethyl-
amine). Ammonia also modulates BBB transport of the
cationic amino acids: the nitric oxide precursor, arginine,
and ornithine, which is an ammonia trap, and affects the
transport of energy metabolites glucose and creatine.
Moreover, ammonia acting either directly or in synergy
with liver injury-derived inﬂammatory cytokines also
evokes subtle increases of the transcellular passage of
molecules of different size (BBB ‘‘leakage’’), which
appears to be responsible for the vasogenic component of
cerebral edema associated with ALF.
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Introductory Comments
Homeostasis of the brain is maintained owing to its rigidly
controlled communication with the peripheral tissues.
Entry of metabolites from the periphery to the brain is
controlled by the blood brain barrier (BBB). The major
structural constituents of the BBB are the cerebral micro-
vascular endothelial cells, and their barrier function relies
on so- called ‘‘tight-junctions’’ (TJs), consisting of trans-
membrane components: junctional adhesion molecule
(JAM)-1, occludin, and the claudins and intracellular pro-
teins: ZO-1, ZO-2, and ZO-3, which link transmembrane
proteins to the actin ﬁlaments of cytoskeleton and in this
way improve stability and functioning of the TJ. Adherent
junctions which are located in the basal region below the
TJs, also contribute to the barrier function. Cadherins sta-
bilize adhesion between neighboring endothelial cells,
while intracellularly, catenins link cadherins to the cyto-
skeleton (Fig. 1). The BBB is both physical and metabolic
in its nature. Physically, the TJs limit free paracellular
diffusion of low molecular weight compounds and make
the transcellular transport of larger molecules dependent
on speciﬁc transport systems, which can be grouped
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and Davis 2005; Carvey et al. 2009). These transport sys-
tems are located in endothelial cells, and are modulated
both intrinsically and by other cells of the neurovascular
unit: astrocytes and pericytes (Simard and Nedergaard
2004). Fine-tuning of the transport involves its polarization
by differential location of the transport systems in the
luminal versus abluminal membranes, which holds in
particular for the different amino acid transport systems
(Hawkins et al. 2006). In this way two ultimate and com-
plementary goals are reached: (i) control of the inﬂow and
outﬂow of metabolic precursors and products, (ii) preven-
tion of entry to the brain of undesired compounds.
The sections below describes the evolution of views on
the role of BBB changes in the pathogenesis of diseases
associated with increased exposure of the brain to blood-
derived ammonia. ‘‘Studies on BBB penetration by dif-
ferent compounds in HE models: a historical account’’
section gives a historical perspective on the experimental
studies on ammonia- and HE-induced changes in BBB
penetration of different compounds, without emphasis on
the underlying mechanisms. ‘‘Transcellular passage of
different molecules across the endothelium: roles of active
transport’’ section of the review will elaborate on the rel-
atively well explored subject of modulation of transcellular
passage, which represents active transport of medium- to
large-molecules, and channel- or transporter-mediated ion
ﬂuxes across the capillary endothelial cell membranes.
‘‘BBB leakage induced by ammonia and inﬂammatory
molecules: new vistas on the underlying mechanisms’’
section is devoted to the new ﬁndings regarding the
mechanisms underlying alterations in the paracellular
transport which is deﬁned as BBB leakage, the role
of which in ammonia neurotoxicity has so far been
underestimated.
Studies on BBB Penetration by Different Compounds
in HE Models: A Historical Account
Pioneering studies pertinent to the effect of ammonia on
BBB permeability were performed on animals with porta-
caval anastomosis (PCA)—a model which mimics the
condition of portal-systemic shunting in patients with liver
cirrhosis. Laursen et al. (1975) showed that BBB in PCA
rats is leaky to horseradish peroxidase (HRP). This obser-
vation has been conﬁrmed by Sumner (1982) in a similar
experimental setting, and by others using different BBB
permeability markers and/or HE models: by Zaki (1983)
also in PCA rats who measured amino acid inﬂux using the
Oldendorf perfusion technique (Oldendorf 1971), and by
Horowitz et al. (1983) in galactosamine-induced animal
model of acute liver failure (ALF), where permeability
changes to a—aminoisobutyric acid were measured.
However, other contemporary animal studies often per-
formed in similar HE models and using similar markers,
revealed no brain vascular permeability changes. Examples
include the absence of changes of sucrose and methyl-
aminoisobutyric acid permeation in galactosamine—
induced HE (Lo et al. 1987), and to mannitol or ions in the
PCA model (Sarna et al. 1977; Alexander et al. 2000). As
will be discussed in ‘‘Transcellular passage of different
molecules across the endothelium: roles of active trans-
port’’ and ‘‘BBB leakage induced by ammonia and
inﬂammatory molecules: new vistas on the underlying
mechanisms’’ sections, controversies about the BBB status
as assessed with different compounds have lasted until the
present time, with BBB changes being either conﬁrmed
(Wang et al. 2011) or denied (Goldbecker et al. 2010).
Incoherent results were also obtained with regard to the
passage of ammonia through the BBB, as monitored with
13N-labeled ammonia (PET technique). Lockwood et al.
(1991) showed that ammonia enters the brain more easily
in advanced HE patients than in healthy controls. By
contrast Goldbecker et al. (2010) did not see any differ-
ences in BBB permeability for ammonia between patients
with and without liver failure. Sørensen et al. (2007)
observed increased ammonia accumulation in cirrhotic
patients, but in their hands the increase was solely attrib-
utable to increased blood ammonia content.
Understanding of the effects of hyperammonemia on
ammonia passage will require separate analysis of the two
different forms of ammonia. At physiological pH over-
whelming proportion of ammonia occurs as a cation
(Warren 1962), so it enters the brain mainly by a trans-
cellular route, using an array of potassium channels and
transporters or by substituting other cations with similar
hydrated radius (Ott and Larsen 2004). One article indi-
cated the presence of a speciﬁc NH4
? carrier the Rhesus
associated glycoprotein RhCG in the brain capillaries
Fig. 1 Composition of the tight junction and adherence junction
which collectively restrict the paracellular passage of solutes across
the BBB
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123(Huang and Liu 2001) but its location (luminal vs. ablu-
minal side) and functionality remains to be conﬁrmed.
However, recently the pericellular penetration by gaseous
ammonia is being taken under consideration as a signiﬁcant
alternative (Ott and Larsen 2004). It is not known which of
the two routes would be affected under excessive ammonia
load.
On the top of these controversies, increased vesicular
transport across endothelial cells and swelling of astrocytic
end-feet has been observed in different HE models
(Pilbeam et al. 1983), with TJs remaining intact (Kato et al.
1992). It would thus appear that altered transcellular pas-
sage maybe a frequent phenomenon, albeit BBB changes in
HE are often too subtle to be detected with markers of
gross BBB leakage.
Transcellular Passage of Different Molecules Across
the Endothelium: Roles of Active Transport
Amino Acids
PCA in rats is associated with amino acid imbalance in
CSF and brain due to enhanced blood to brain transport of
tryptophan and other members of large neutral amino acid
group (LNAA) (James et al. 1978). In addition, increased
concentration of aromatic amino acids (AAA) was found in
brains of rats with PCA, while the level of branched-chain
amino acids was decreased (Smith et al. 1978). The above
observations prompted a hypothesis that these alterations
may contribute to impaired neurotransmission in HE by
producing (i) excessive amounts of neurotransmitters from
which they derive, and/or (ii) ‘‘false’’ instead of ‘‘authen-
tic’’ neurotransmitters, which are similar in structure but
are either not active at the postsynaptic membrane, or their
activity differs from their ‘‘true’’ counterparts (Curzon
et al. 1975). The ‘‘false neurotransmitter’’ hypothesis
appears attractive, because AAA are also precursors of
these ‘‘false’’ modulators: tyrosine for octopamine; phen-
ylalanine for phenylethanolamine. Indeed, James et al.
(1976) and Cangiano et al. (1982) showed elevated brain
octopamine and phenylethanolamine levels in the brains of
PCA rats, and Hilgier et al. (1985) in the brains of rats with
thioacetamide-induced liver failure. However, the contri-
bution of these false neurotransmitters to the neurotrans-
mission imbalance associated with HE has insofar not been
examined in more detail.
A plausible explanation for the ammonia-induced
increase of blood–brain AAA transport activity was pro-
posed by James and colleagues (1979) who hypothesized
that during hyperammonemia, increased brain glutamine
(Gln) production is followed by increased Gln efﬂux from
the brain, resulting in increased inward transport of these
amino acids. This inference has been proven directly in
studies in which increased tryptophan (Try) uptake in
exchange with Gln via the L-transport system was recorded
in cerebral capillary microvessels isolated from PCA rats
(Cangiano et al. 1983). Vice versa, release of newly loaded
Gln from the capillaries was promoted by the Try and
leucine (Leu), and the effect was more pronounced when
the capillaries were isolated from TAA rats or following
their incubation with ammonia than in control preparations
(Hilgier et al. 1992). In the in situ setting, Rigotti et al.
(1985) showed that treatment of PCA rats with an inhibitor
of Gln synthesis, methionine sulfoximine (MSO), reduced
the increased accumulation of the AAA in the brain in a
manner correlated with increased ammonia accumulation.
Furthermore, Hawkins et al. (1993) showed that adminis-
tration of MSO to PCA rats normalized amino acid
imbalance ascribed to excessive Gln production.
Hyperammonemia was shown to be directly responsible
for PCA-induced alterations in the metabolism and
transport of amino acids (Jessy et al. 1990), including
elevated brain Try content and rise in the brain level of a
serotonin metabolite, 5-hydroxyindoleacetic acid. These
effects appeared to be due to ammonia-induced functional
impairment of LNAA transport at the BBB. In rats in which
HA was executed by urease administration, the impairment
was found closely correlated with the rise in brain Gln
content (Bachmann and Colombo 1983), while in the
cortical capillaries the increased Try-Gln exchange could
be related to the raised c-glutamyl-transpeptidase (GGT)
activity (Stastny ´ et al. 1988). Because GGT participates in
LNAA transport and its activity was found to be increased
in brain capillaries from hyperammonemic rats, a hypoth-
esis has been put forward that GGT is involved in trig-
gering the outward transport of the excess of Gln from
brain (Gorgievski-Hrisoho et al. 1986). In this way,
enhanced activation of GGT could contribute to raised Try
and other LNAA levels as observed in rats with TAA-
induced ALF (Hilgier et al. 1990). The above speculations
were conﬁrmed in a follow up study from the author’s
laboratory showing that GGT affects the L system-medi-
ated amino acid exchange (Hilgier et al. 1992).
The BBB transport of the cationic amino acids arginine
(Arg) and ornithine (Orn) was investigated in different HE
models, and contradictory results have been obtained. Zaki
et al. (1984) showed a 30% increase in the brain uptake of
Arg in the galactosamine model of hepatic failure; how-
ever, the effect was not speciﬁc to this amino acid and
possibly secondary to BBB leakage also revealed by high
molecular weight markers. By contrast, Arg uptake from
blood to brain was found decreased in chronic HE (PCA)
rats (Zanchin et al. 1979) and in rats with thioacetamide
(TAA)-induced HE (Albrecht et al. 1996). With regard to
Orn, increased brain uptake index of this amino acid
238 Neurotox Res (2012) 21:236–244
123coincident with its increased content in the blood was
found in the TAA model of HE (Albrecht and Hilgier 1986;
Albrecht et al. 1994 1996; Albrecht et al. 1996). Increased
BBB transport of Orn in the TAA model has been con-
sidered as auto-protective response and in the same line has
been speculated to facilitate intracerebral therapeutic
action of the ammonia-trapping drug, L-ornithine-L-aspar-
tate (LOLA) (Albrecht et al. 1994; Albrecht et al. 1996).
However, the beneﬁts of Orn may not apply to HE in a
chronic setting, where blood to brain transport of Orn
appears to remain unchanged (Zanchin et al. 1979).
The mechanism underlying alterations of BBB transport
of Arg and Orn has been hypothesized to involve changes
in the basic amino acid transporter y
? activity and com-
petition between these two amino acids for the transport
site (Albrecht et al. 1996), but experimental evidence in
support of this hypothesis has not been provided as yet. The
effects of HE on Arg transport are also likely to be medi-
ated by Gln, which accumulates intracerebrally in conse-
quence of increased ammonia inﬂux (Cooper and Plum
1987), overloading different cellular and subcellular com-
partments of the CNS (Albrecht 2010). It has been shown
that Gln added exogenously reduces NO generation in the
brain by inhibiting Arg transport via the Arg/Gln exchan-
ger, y
?LAT2, and that this effect is potentiated when
ammonia is infused directly to the brain (Hilgier et al.
2009), or accumulates in there during HE (Zielin ´ska et al.
2011). If the above mechanism operates not only in the
CNS cells but also in the cerebral capillary endothelial
cells forming the BBB, enhanced Gln accumulation would
modulate Arg transport in these cells. The ﬁnal outcome of
this interaction would depend on whether Gln accumulates
intra- or extra-cellularly. A hypothesis that such an inter-
action may occur is supported by the observation that, Gln
infusion in the absence of hyperammonemia impairs
cerebrovascular CO2 reactivity, most likely by reducing
Arg availability and NO synthesis, because co-infusion of
Arg counteracts the effect caused by glutamine (Okada
et al. 2000). Consistent with the role of Arg/Gln exchange
at the BBB, our preliminary data indicate that ammonia
increases the expression of the y
?LAT2 transporter in a
cerebral capillary endothelial cell line (manuscript in
preparation), as it does in the brain in the course of HA in
situ (Zielin ´ska et al. 2011).
Further studies on the mechanisms and pathophysio-
logical implications of the changes in Arg or Orn inﬂux to
the brain are warranted in view of the proven or suspected
contributions of the amino acids to the pathogenesis of HE.
Arg is a precursor of NO, a compound whose increased
accumulation is engaged in the inﬂammatory response of
the brain to ammonia (Jalan et al. 2011), and in ammonia-
induced brain swelling (Ha ¨ussinger and Go ¨rg 2010), while
decreased NO synthesis has been implicated in impairment
of cognition associated with prolonged hyperammonemia
(Felipo 2006). Moreover, HA increases Arg uptake to the
different cell types within the CNS (Rao et al. 1997; Hazell
et al. 1998), and HE in the TAA model stimulates Arg
conversion to the neurotransmitter amino acids Glu and
GABA as measured in the whole brain (Albrecht and
Hilgier 1986) and in synaptosomes derived from these rats,
which is likely to alter the balance between the inhibitory
and excitatory neurotransmission (Albrecht et al. 1990).
Evaluation of the contribution of changes in Arg transport
across the BBB to the availability of this amino acid in the
brain cannot be accomplished without accounting for the
variability in blood Arg content in the different hyperam-
monemic models. The plasma Arg level was shown to be
decreased in PCA rats (Zanchin et al. 1979), but was ele-
vated in rats subjected to prolonged hyperammonemia
(Ishihara et al. 1998), and ﬂuctuated from increase to
decrease during the development of TAA-induced HE
(Albrecht and Hilgier 1986).
Orn plays a role in ammonia detoxiﬁcation and gives
rise to polyamines which exert hepato- and neuroprotection
(Sikorska et al. 2010; Seiler 2000). Treatment with LOLA,
where Orn contributes to urea formation, reduces blood
ammonia level and in consequence improves the general
condition of HE patients (Kircheis et al. 2002; Toris et al.
2011). In this light, increased brain uptake of Orn as found
in the TAA model of HE would further promote protection
(Albrecht et al. 1994).
Orn also contributes in some degree to the biosynthesis
of the neurotransmitter amino acids Glu and GABA
(Shank and Campbell 1983). Similar to Arg, conversion of
its product Orn to Glu/GABA is stimulated during HE
(Albrecht and Hilgier 1986; Albrecht et al. 1990). How-
ever, implications for this increased conversion for neu-
rotransmission imbalance associated with HE are not
known.
Taurine (Tau) is a sulfur amino acid largely implicated
in osmoregulatory and neuroprotective responses of the
brain in various diseases, including hyperammonemia and
HE (Bosman et al. 1992; Butterworth 1996; Faff et al.
1997; Zielinska et al. 2003). Volume regulatory properties
of Tau are thought to be of particular importance in the
case of brain edema, a major consequence of hyperam-
monemia, which results from impaired water homeostasis
followed by swelling of astrocytes (Blei 2005). HE but not
HA was associated with elevated blood content and
increased brain uptake from blood to brain of Tau, which
collectively contributed to the increase of Tau level in
cerebral cortex (Hilgier et al. 1996). Similar observation
that liver failure induces elevation of Tau in the blood
were also made by other authors (Hamberger and Nystro ¨m
1984; Zimmermann et al. 1989). Because increased pas-
sage of Tau was not due to massive breakdown of BBB
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which is not transported by intact capillary endothelial
cells), it was believed to reﬂect activation of a Tau trans-
port system (Hilgier et al. 1996). Of note in this context,
treatment of an endothelial cell line with ammonia led to
up-regulation and increased function of Tau transporter
(Be ´langer et al. 2007).
Energy Substrates
Hyperammonemia by affecting BBB transport of different
substances and molecules can also lead to disturbances in
cerebral energy homeostasis. Hepatic encephalopathy
evoked by PCA was demonstrated to be associated with
decreased brain glucose use and energy metabolism
(DeJoseph and Hawkins 1991), and a similar effect was
noted in rats with TAA-induced HE (Hilgier et al. 1991).
Brain uptake index of glucose was reduced after PCA in rats
(Sarna et al. 1979; Crinquette et al. 1982) and this decrease
was almost entirely due to the decrease in plasma glucose
concentrations (Mans et al. 1986). GLUT-1, the principal
glucose transporter at the BBB responsible for supplying
CNS cells with blood-borne glucose was demonstrated to be
induced by ALF (Be ´langer et al. 2006). Since inhibition of
glucose oxidative metabolism and subsequent activation of
cerebral glycolysis are a hallmark of brain energy metab-
olism in HE animals (Zwingmann et al. 2003; Rao and
Norenberg 2001), increased expression of GLUT-1 maybe
considered as a compensatory response aimed at supporting
higher glycolysis and maintaining brain ATP levels.
Creatine (Cr) a key substrate of the creatine/phospho-
creatine/creatine kinase pathway is involved in regenera-
tion of ATP and in this way it also contributes to brain
energy metabolism. Moreover, Cr was shown to affect
GABA-ergic neurotransmission by acting as partial agonist
on post-synaptic GABA(A) receptors (Cupello et al. 2008)
and to be crucial in dendritic and axonal elongation
(Braissant et al. 2002). Exposure to ammonia was shown to
generate a deﬁciency in Cr in CNS cells and to lead to
neuronal cell loss, while co-treatment with Cr was neuro-
protective under ammonia exposure, but only in the pres-
ence of astrocytes (Braissant 2002). Ammonia treatment
was demonstrated to increase Cr uptake in cultured mi-
crocapillary brain endothelial cells (Be ´langer et al. 2007),
which probably reﬂects a neuroprotective response.
BBB Leakage Induced by Ammonia and Inﬂammatory
Molecules: New Vistas on the Underlying Mechanisms
Recent studies conﬁrmed the view that hyperammonemia
produces subtle changes in BBB integrity and partly
unraveled the underlying mechanism. Brain extravasation
and edema in azoxymethane-induced ALF were found to
be secondary to tight junction (TJ) protein degradation
mediated by activation of matrix metalloproteinase-9
(MMP-9) (Nguyen et al. 2006). Speciﬁcally, it has been
shown that TJ proteins occludin and claudin-5 are signiﬁ-
cantly degraded in the brains of mice with galactosamine-
induced ALF, and this effect was reversed by treatment
with inhibitor of MMP-9, GM6001 (Chen et al. 2009). A
recent study delineated the most likely sequence of events
linking activation of MMP-9 to occludin degradation in
ALF mice; the intermediate steps include transactivation of
epidermal growth factor receptor (EGFR) and p38 MAPK/
NFjB (mitogen-activated protein kinase/nuclear factor-
kappa B) (Chen et al. 2011). Cauli et al. (2011) observed
that progression of intracranial pressure in the course of
ALF is strictly correlated with the increase in BBB per-
meability and MMP-9 content. Basing on this study the
authors proposed a sequence of events of ALF-induced
brain damage, in which increase in BBB permeability is an
initial step leading to vasogenic edema followed by
ammonia excitotoxicity and cytotoxic edema.
Inﬂammatory molecules, including cytokines (IL-1 and/
or IL-6) and tumor necrosis factor-alpha (TNF-a) are
increased in plasma during acute and chronic liver failure
in patients (Tilg et al. 1992; Wright et al. 2007), and in
animals with experimentally-induced HE (Jiang et al.
2009). Circulating levels of TNF-a correlate positively
with the severity of HE (Odeh et al. 2005), moreover, its
involvement in the development of intracranial pressure in
patients with ALF was demonstrated (Jalan et al. 2004).
Plasma IL-6 level was also found well correlated with the
severity of HE and morbidity of the patients (Sheron et al.
1991). Because massive breakdown of BBB is not
observed during HE, it is believed that the effects of
inﬂammatory cytokines are transduced to the CNS by vaso-
active agents such as nitric oxide or prostanoids, which are
synthesized by BBB-forming endothelium (Licinio and
Wong 1997). However, TNF-a was recently shown to
directly affect the blood–brain barrier permeability in ALF
animals in the galactosamine (Lv 2010) and APAP model
(Wang et al. 2011) and in human ALF patients (Lv 2010),
by disrupting TJs and inducing loss of the TJ-associated
protein occludin (Lv 2010).
Conclusions and Perspectives
Data presented in this review provide considerable evi-
dence that ammonia alters the passage of different mole-
cules across the BBB, both by the transcellular route
representing active or facilitated transport, and paracellu-
larly, which occurs due to changes in the integrity of BBB
constituents and thus reﬂects BBB leakage. As discussed
above, increased BBB permeability adds a vasogenic
240 Neurotox Res (2012) 21:236–244
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HE (Cauli et al. 2011).
The effects of ammonia on the carrier-mediated trans-
port of different molecules by the cerebral endothelial cells
have been studied in considerable detail and the outlines of
the changes in amino acid or energy metabolite transport
are relatively well described. By contrast, the transcellular
transport has long been given little consideration, mainly
because in most HE models, the ammonia-or HE-induced
changes have been too subtle and spatially restricted to be
visualized by standard light- and electron microscopic
techniques. The advent of more sensitive techniques has
made it possible to identify the changes in TJ proteins and
their environment in a microscale, and provided tools to
bridge the observations to the molecular mechanisms
underlying the BBB leakage. Further studies in this
direction should allow to distinguish between the BBB
changes in HE which are induced directly by ammonia and
those related to inﬂammatory toxins, mostly cytokines.
One aspect deserving consideration in the future studies is
the potential role of free radicals of oxygen and nitrogen,
which have been found to be generated in excess by
ammonia in different models and cell types of the CNS and
are responsible for the oxidative/nitrosative stress (ONS)
(Bemeur et al. 2010;H a ¨ussinger 2010; Skowron ´ska et al.
2010). Preliminary results from our laboratory disclosed
that ONS markers accumulate in an ammonia-treated brain
microvascular endothelial cell line and increase perme-
ability of these cells to a high molecular weight marker
(Skowron ´ska et al., manuscript in preparation). This line of
investigation appears attractive in view of the fact that
ONS causes BBB dysfunction in brain pathologies of
varying etiology and severity (Lehner et al. 2011). Many of
the intracellular derangements known to be induced by
ammonia in the cells within the CNS or in peripheral tis-
sues are likely to hold for the BBB-forming cerebral vas-
cular endothelial cells, and may converge with events
triggered in the different cells by ONS. Of note activation
of the p38 MAPK/NFjB pathway which underlies MMP-9-
induced TJ protein damage (Chen et al. 2011), is also
involved in ammonia-induced oxidative damage of astro-
cytes (Jayakumar et al. 2006; Sinke et al. 2008). Other
targets may include, for instance, altered Nrf2-mediated
synthesis of heme oxygenase I, an effect common to the
response to various blood brain barrier damaging condi-
tions (Lehner et al. 2011) and to the ammonia-induced
ONS in astrocytes (Warskulat et al. 2002). Clearly, the
above described mechanisms do not exhaust the list of
possibilities that are worth further investigation.
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